
Erinne R. Dabkowski
Examiner (ID: 9598, Phone: (571)272-1829 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1654, 1675 |
| Total Applications | 857 |
| Issued Applications | 384 |
| Pending Applications | 153 |
| Abandoned Applications | 353 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17213140
[patent_doc_number] => 20210346476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => Modified FVIII Apitope Peptides
[patent_app_type] => utility
[patent_app_number] => 17/239251
[patent_app_country] => US
[patent_app_date] => 2021-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9237
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17239251
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/239251 | Modified FVIII Apitope Peptides | Apr 22, 2021 | Abandoned |
Array
(
[id] => 17928421
[patent_doc_number] => 20220323546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => RECOMBINANT INTERFERON
[patent_app_type] => utility
[patent_app_number] => 17/235654
[patent_app_country] => US
[patent_app_date] => 2021-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15882
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17235654
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/235654 | RECOMBINANT INTERFERON | Apr 19, 2021 | Pending |
Array
(
[id] => 17505158
[patent_doc_number] => 20220098260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => BH4 Stabilized Peptides And Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/232678
[patent_app_country] => US
[patent_app_date] => 2021-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39331
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17232678
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/232678 | BH4 Stabilized Peptides And Uses Thereof | Apr 15, 2021 | Pending |
Array
(
[id] => 17020928
[patent_doc_number] => 20210244799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => USES OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS FOR TREATING TRAUMA-INDUCED HEARING LOSS
[patent_app_type] => utility
[patent_app_number] => 17/231381
[patent_app_country] => US
[patent_app_date] => 2021-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7357
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231381
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/231381 | USES OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS FOR TREATING TRAUMA-INDUCED HEARING LOSS | Apr 14, 2021 | Abandoned |
Array
(
[id] => 18535880
[patent_doc_number] => 20230240966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING HAIR FOLLICLE-LINKED CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/996256
[patent_app_country] => US
[patent_app_date] => 2021-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15632
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996256
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/996256 | COMPOSITIONS AND METHODS FOR TREATING HAIR FOLLICLE-LINKED CONDITIONS | Apr 14, 2021 | Pending |
Array
(
[id] => 17156122
[patent_doc_number] => 20210317173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => COMPOSITIONS AND METHODS FOR FABRICATING SYNTHETIC DRAGLINE SPIDER SILK
[patent_app_type] => utility
[patent_app_number] => 17/230147
[patent_app_country] => US
[patent_app_date] => 2021-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17597
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17230147
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/230147 | COMPOSITIONS AND METHODS FOR FABRICATING SYNTHETIC DRAGLINE SPIDER SILK | Apr 13, 2021 | Abandoned |
Array
(
[id] => 19316822
[patent_doc_number] => 20240238362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => ANTI-OBESITY PEPTIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/917618
[patent_app_country] => US
[patent_app_date] => 2021-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12304
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17917618
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/917618 | ANTI-OBESITY PEPTIDES AND USES THEREOF | Apr 5, 2021 | Pending |
Array
(
[id] => 18418566
[patent_doc_number] => 20230173024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => FACTOR B INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/995194
[patent_app_country] => US
[patent_app_date] => 2021-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36772
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995194
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995194 | FACTOR B INHIBITORS AND USES THEREOF | Mar 31, 2021 | Pending |
Array
(
[id] => 18497399
[patent_doc_number] => 20230220029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => ANTIVIRAL BIOMIMETIC PEPTIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/997038
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5855
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997038
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/997038 | ANTIVIRAL BIOMIMETIC PEPTIDES AND USES THEREOF | Mar 25, 2021 | Pending |
Array
(
[id] => 18544225
[patent_doc_number] => 11717557
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-08
[patent_title] => Use of PRG4 as an anti-inflammatory agent
[patent_app_type] => utility
[patent_app_number] => 17/194747
[patent_app_country] => US
[patent_app_date] => 2021-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 31
[patent_no_of_words] => 19186
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194747
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/194747 | Use of PRG4 as an anti-inflammatory agent | Mar 7, 2021 | Issued |
Array
(
[id] => 17312695
[patent_doc_number] => 20210401743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => Leucine/Peptide Composition and Method of Formulation
[patent_app_type] => utility
[patent_app_number] => 17/192818
[patent_app_country] => US
[patent_app_date] => 2021-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2612
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17192818
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/192818 | Leucine/Peptide Composition and Method of Formulation | Mar 3, 2021 | Abandoned |
Array
(
[id] => 17200116
[patent_doc_number] => 20210340211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => GIP PEPTIDE ANALOGUES
[patent_app_type] => utility
[patent_app_number] => 17/188805
[patent_app_country] => US
[patent_app_date] => 2021-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17188805
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/188805 | GIP PEPTIDE ANALOGUES | Feb 28, 2021 | Pending |
Array
(
[id] => 17005238
[patent_doc_number] => 20210236399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => REAGENTS AND METHODS FOR MINERALIZATION OF TOOTH ENAMEL
[patent_app_type] => utility
[patent_app_number] => 17/177918
[patent_app_country] => US
[patent_app_date] => 2021-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20982
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17177918
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/177918 | REAGENTS AND METHODS FOR MINERALIZATION OF TOOTH ENAMEL | Feb 16, 2021 | Abandoned |
Array
(
[id] => 18253231
[patent_doc_number] => 20230080270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => NANOPARTICLES ENCAPSULATING SMALL MOLECULES
[patent_app_type] => utility
[patent_app_number] => 17/760381
[patent_app_country] => US
[patent_app_date] => 2021-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30497
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17760381
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/760381 | NANOPARTICLES ENCAPSULATING SMALL MOLECULES | Feb 13, 2021 | Pending |
Array
(
[id] => 17124255
[patent_doc_number] => 20210299023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => COMPOSITIONS AND METHODS FOR HAIR GROWTH
[patent_app_type] => utility
[patent_app_number] => 17/172372
[patent_app_country] => US
[patent_app_date] => 2021-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10621
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17172372
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/172372 | COMPOSITIONS AND METHODS FOR HAIR GROWTH | Feb 9, 2021 | Abandoned |
Array
(
[id] => 16870076
[patent_doc_number] => 20210163543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => SYNTHETIC PEPTIDE COMPOUNDS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/169758
[patent_app_country] => US
[patent_app_date] => 2021-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27573
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17169758
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/169758 | Synthetic peptide compounds and methods of use | Feb 7, 2021 | Issued |
Array
(
[id] => 16837025
[patent_doc_number] => 20210145037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => PROTEIN HYDROLYSATE FOR SHORT TERM RENAL FUNCTIONING
[patent_app_type] => utility
[patent_app_number] => 17/162763
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5472
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17162763
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/162763 | PROTEIN HYDROLYSATE FOR SHORT TERM RENAL FUNCTIONING | Jan 28, 2021 | Abandoned |
Array
(
[id] => 18748397
[patent_doc_number] => 11807693
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-07
[patent_title] => Apelin polypeptides
[patent_app_type] => utility
[patent_app_number] => 17/160819
[patent_app_country] => US
[patent_app_date] => 2021-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 26
[patent_no_of_words] => 55386
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17160819
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/160819 | Apelin polypeptides | Jan 27, 2021 | Issued |
Array
(
[id] => 16946742
[patent_doc_number] => 20210205433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => Vaccines against Chlamydia sp.
[patent_app_type] => utility
[patent_app_number] => 17/155264
[patent_app_country] => US
[patent_app_date] => 2021-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19506
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17155264
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/155264 | Vaccines against Chlamydia sp. | Jan 21, 2021 | Pending |
Array
(
[id] => 16822749
[patent_doc_number] => 20210138042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => FORMULATIONS FOR NUTRITIONAL SUPPORT IN SUBJECTS IN NEED THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/155759
[patent_app_country] => US
[patent_app_date] => 2021-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22868
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17155759
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/155759 | FORMULATIONS FOR NUTRITIONAL SUPPORT IN SUBJECTS IN NEED THEREOF | Jan 21, 2021 | Pending |